Boston Scientific Corp (BSX)
68.56
+0.54
(+0.79%)
USD |
NYSE |
Apr 23, 12:31
Boston Scientific Cash from Investing (Quarterly): -1.053B for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.053B |
| September 30, 2023 | -197.00M |
| June 30, 2023 | -840.00M |
| March 31, 2023 | -484.00M |
| December 31, 2022 | -183.00M |
| September 30, 2022 | -225.00M |
| June 30, 2022 | -29.00M |
| March 31, 2022 | -1.574B |
| December 31, 2021 | -461.00M |
| September 30, 2021 | -1.207B |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 71.00M |
| December 31, 2020 | -147.00M |
| September 30, 2020 | -129.00M |
| June 30, 2020 | -59.00M |
| March 31, 2020 | -76.00M |
| December 31, 2019 | -49.00M |
| September 30, 2019 | -3.962B |
| June 30, 2019 | -620.00M |
| March 31, 2019 | -410.00M |
| December 31, 2018 | -595.00M |
| September 30, 2018 | -662.00M |
| June 30, 2018 | -491.00M |
| March 31, 2018 | -173.00M |
| December 31, 2017 | -289.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -102.00M |
| June 30, 2017 | -479.00M |
| March 31, 2017 | -140.00M |
| December 31, 2016 | -532.00M |
| September 30, 2016 | -205.00M |
| June 30, 2016 | -102.00M |
| March 31, 2016 | -48.00M |
| December 31, 2015 | -170.00M |
| September 30, 2015 | -1.719B |
| June 30, 2015 | -246.00M |
| March 31, 2015 | -51.00M |
| December 31, 2014 | -83.00M |
| September 30, 2014 | -473.00M |
| June 30, 2014 | -124.00M |
| March 31, 2014 | -65.00M |
| December 31, 2013 | -363.00M |
| September 30, 2013 | -73.00M |
| June 30, 2013 | -28.00M |
| March 31, 2013 | -11.00M |
| December 31, 2012 | -273.00M |
| September 30, 2012 | -53.00M |
| June 30, 2012 | -187.00M |
| March 31, 2012 | -66.00M |
| December 31, 2011 | -51.00M |
| September 30, 2011 | -59.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.962B
Minimum
Sep 2019
71.00M
Maximum
Mar 2021
-590.74M
Average
-197.00M
Median
Sep 2023
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp | -152.00M |
| Abbott Laboratories | -824.00M |
| Edwards Lifesciences Corp | 14.10M |
| Intuitive Surgical Inc | -128.50M |
| Axonics Inc | -37.92M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 957.00M |
| Cash from Financing (Quarterly) | 15.00M |
| Free Cash Flow | 1.703B |
| Free Cash Flow Per Share (Quarterly) | 0.4673 |
| Free Cash Flow to Equity (Quarterly) | 488.00M |
| Free Cash Flow to Firm (Quarterly) | 732.91M |
| Free Cash Flow Yield | 1.70% |